文献速递造血干细胞移植与细胞治疗

细胞治疗医疗旅游的临床视角

Medical tourism for cellular therapy: a clinical perspective.
PubMed 文献 · Lancet Haematol · 2025-01-01

该观点文章探讨细胞治疗领域日益增长的医疗旅游现象,聚焦造血干细胞移植和CAR-T细胞治疗,讨论全球现状、监管挑战与伦理考量,区分受监管的循证细胞治疗与未经证实的干细胞旅游,并强调多学科团队、远程医疗和国际合作对改善患者结局的重要性。

要点

  • 细胞治疗医疗旅游近十年指数增长,需区分循证治疗与未经验证的干细胞旅游。
  • 区域细胞治疗中心的经验强调多学科团队、远程医疗和国际协作对患者支持的重要性。
  • 医疗旅游可成为改善来源国医疗公平的催化剂,但需应对监管与伦理挑战。

核心结论

  • 细胞治疗医疗旅游增长迅速,需区分受监管的循证治疗与高风险未经验证的干细胞旅游。
  • 通过多学科团队、远程医疗整合和国际合作可改善医疗旅游患者结局。
  • 医疗旅游有潜力成为改善全球医疗公平的催化剂。

研究设计与样本

  • 观点文章,基于区域细胞治疗中心的实践经验提供见解。

主要发现

  • 细胞治疗医疗旅游近十年呈指数增长。
  • 医疗旅游对患者护理和当地医疗系统既有益处也有弊端。
  • 未经验证的干细胞旅游利用脆弱患者,存在风险。

临床怎么用

  • 强调综合患者支持需通过多学科团队、远程医疗整合和国际合作实现。
  • 需区分受监管的循证细胞治疗与 risky 未经验证的干细胞旅游。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medical tourism in the field of cellular therapy has been increasing exponentially, especially in the past decade, due to multiple advances in the field. Our Viewpoint explores this growing field, with a specific focus on haematopoietic stem-cell transplantation (HSCT) and chimeric antigen receptor (CAR) T-cell therapy. We discuss the global status, regulatory challenges, and ethical considerations associated with medical tourism. We highlight benefits and drawbacks of medical tourism with regard to patient care and the impact on local health-care systems. We also address the crucial distinction between regulated, evidence-based cellular therapies and risky, unproven stem-cell tourism, which preys on vulnerable patients. We offer practical insights from our experience practicing in a regional cellular therapy hub and emphasise the importance of comprehensive patient support through a multidisciplinary team, telemedicine integration, and international collaboration to improve patient outcomes. Last, we provide perspective and suggestions on how medical tourism can be a catalyst for change within patients' countries of origin in order to improve global health-care equity.

来源:Lancet Haematol,查看原文。版权归原作者所有。

引用

  1. Esther CHL, Fan EB, Hew YY, et al. Medical tourism for cellular therapy: a clinical perspective. Lancet Haematol. 2025. PMID: 41338866. doi:10.1016/S2352-3026(25)00294-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。